Cargando…

The current extent of and need for shared decision making in atopic dermatitis and psoriasis in the Netherlands: an online survey study amongst patients and physicians

BACKGROUND: In shared decision making (SDM), patients and physicians work together to choose the best treatment option for an individual patient. Atopic dermatitis (AD) and psoriasis are particularly suitable for SDM, considering that the best treatment option depends on a patient’s preferences and...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Kraaij, G.E., Vermeulen, F.M., Smeets, P.M.G., Smets, E.M.A., Spuls, P.I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818257/
https://www.ncbi.nlm.nih.gov/pubmed/32163645
http://dx.doi.org/10.1111/jdv.16340
_version_ 1783638797879083008
author van der Kraaij, G.E.
Vermeulen, F.M.
Smeets, P.M.G.
Smets, E.M.A.
Spuls, P.I.
author_facet van der Kraaij, G.E.
Vermeulen, F.M.
Smeets, P.M.G.
Smets, E.M.A.
Spuls, P.I.
author_sort van der Kraaij, G.E.
collection PubMed
description BACKGROUND: In shared decision making (SDM), patients and physicians work together to choose the best treatment option for an individual patient. Atopic dermatitis (AD) and psoriasis are particularly suitable for SDM, considering that the best treatment option depends on a patient’s preferences and values (preference‐sensitive decisions). Currently, it is unknown to what extent SDM is applied in treatment decisions for these diseases in the Netherlands. OBJECTIVES: Primary, to assess the current extent of SDM in AD and psoriasis in the Netherlands amongst patients and dermatologists. Secondary, to assess the degree to which patients and physicians endorse SDM, to explore which characteristics are related to their preference to be involved in SDM and to identify which barriers and facilitators for SDM they perceive. METHODS: Two similar online surveys, one for patients with AD or psoriasis and one for (resident) dermatologists, were carried out. The surveys comprised validated questionnaires (shared decision making questionnaire (SDM‐Q; range 0–100), Control Preference Scale) and study‐specific statements mainly regarding barriers and facilitators for SDM. RESULTS: The responses of 219 patients and 147 physicians were analysed. Dermatologists experienced significantly more SDM than patients (SDM‐Q 82 vs 55; P < 0.01). Most patients and dermatologists prefer to share treatment decisions. Mainly facilitators for SDM were perceived, including the positive perception of patients and dermatologists regarding SDM. The perceived barriers included lack of continuity of care by the same physician and lack of time. CONCLUSION: Despite the dermatologists’ optimistic perspective, patients experience a limited extent of SDM and physicians should be aware of this gap. Improvement of SDM in AD and psoriasis is needed. The positive attitude of patients and dermatologists towards the process and outcome of SDM is important facilitators, while barriers were mainly perceived on an organizational level.
format Online
Article
Text
id pubmed-7818257
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78182572021-01-29 The current extent of and need for shared decision making in atopic dermatitis and psoriasis in the Netherlands: an online survey study amongst patients and physicians van der Kraaij, G.E. Vermeulen, F.M. Smeets, P.M.G. Smets, E.M.A. Spuls, P.I. J Eur Acad Dermatol Venereol Allergy and Eczema BACKGROUND: In shared decision making (SDM), patients and physicians work together to choose the best treatment option for an individual patient. Atopic dermatitis (AD) and psoriasis are particularly suitable for SDM, considering that the best treatment option depends on a patient’s preferences and values (preference‐sensitive decisions). Currently, it is unknown to what extent SDM is applied in treatment decisions for these diseases in the Netherlands. OBJECTIVES: Primary, to assess the current extent of SDM in AD and psoriasis in the Netherlands amongst patients and dermatologists. Secondary, to assess the degree to which patients and physicians endorse SDM, to explore which characteristics are related to their preference to be involved in SDM and to identify which barriers and facilitators for SDM they perceive. METHODS: Two similar online surveys, one for patients with AD or psoriasis and one for (resident) dermatologists, were carried out. The surveys comprised validated questionnaires (shared decision making questionnaire (SDM‐Q; range 0–100), Control Preference Scale) and study‐specific statements mainly regarding barriers and facilitators for SDM. RESULTS: The responses of 219 patients and 147 physicians were analysed. Dermatologists experienced significantly more SDM than patients (SDM‐Q 82 vs 55; P < 0.01). Most patients and dermatologists prefer to share treatment decisions. Mainly facilitators for SDM were perceived, including the positive perception of patients and dermatologists regarding SDM. The perceived barriers included lack of continuity of care by the same physician and lack of time. CONCLUSION: Despite the dermatologists’ optimistic perspective, patients experience a limited extent of SDM and physicians should be aware of this gap. Improvement of SDM in AD and psoriasis is needed. The positive attitude of patients and dermatologists towards the process and outcome of SDM is important facilitators, while barriers were mainly perceived on an organizational level. John Wiley and Sons Inc. 2020-07-27 2020-11 /pmc/articles/PMC7818257/ /pubmed/32163645 http://dx.doi.org/10.1111/jdv.16340 Text en © 2020 AMC/University of Amsterdam. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Allergy and Eczema
van der Kraaij, G.E.
Vermeulen, F.M.
Smeets, P.M.G.
Smets, E.M.A.
Spuls, P.I.
The current extent of and need for shared decision making in atopic dermatitis and psoriasis in the Netherlands: an online survey study amongst patients and physicians
title The current extent of and need for shared decision making in atopic dermatitis and psoriasis in the Netherlands: an online survey study amongst patients and physicians
title_full The current extent of and need for shared decision making in atopic dermatitis and psoriasis in the Netherlands: an online survey study amongst patients and physicians
title_fullStr The current extent of and need for shared decision making in atopic dermatitis and psoriasis in the Netherlands: an online survey study amongst patients and physicians
title_full_unstemmed The current extent of and need for shared decision making in atopic dermatitis and psoriasis in the Netherlands: an online survey study amongst patients and physicians
title_short The current extent of and need for shared decision making in atopic dermatitis and psoriasis in the Netherlands: an online survey study amongst patients and physicians
title_sort current extent of and need for shared decision making in atopic dermatitis and psoriasis in the netherlands: an online survey study amongst patients and physicians
topic Allergy and Eczema
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818257/
https://www.ncbi.nlm.nih.gov/pubmed/32163645
http://dx.doi.org/10.1111/jdv.16340
work_keys_str_mv AT vanderkraaijge thecurrentextentofandneedforshareddecisionmakinginatopicdermatitisandpsoriasisinthenetherlandsanonlinesurveystudyamongstpatientsandphysicians
AT vermeulenfm thecurrentextentofandneedforshareddecisionmakinginatopicdermatitisandpsoriasisinthenetherlandsanonlinesurveystudyamongstpatientsandphysicians
AT smeetspmg thecurrentextentofandneedforshareddecisionmakinginatopicdermatitisandpsoriasisinthenetherlandsanonlinesurveystudyamongstpatientsandphysicians
AT smetsema thecurrentextentofandneedforshareddecisionmakinginatopicdermatitisandpsoriasisinthenetherlandsanonlinesurveystudyamongstpatientsandphysicians
AT spulspi thecurrentextentofandneedforshareddecisionmakinginatopicdermatitisandpsoriasisinthenetherlandsanonlinesurveystudyamongstpatientsandphysicians
AT vanderkraaijge currentextentofandneedforshareddecisionmakinginatopicdermatitisandpsoriasisinthenetherlandsanonlinesurveystudyamongstpatientsandphysicians
AT vermeulenfm currentextentofandneedforshareddecisionmakinginatopicdermatitisandpsoriasisinthenetherlandsanonlinesurveystudyamongstpatientsandphysicians
AT smeetspmg currentextentofandneedforshareddecisionmakinginatopicdermatitisandpsoriasisinthenetherlandsanonlinesurveystudyamongstpatientsandphysicians
AT smetsema currentextentofandneedforshareddecisionmakinginatopicdermatitisandpsoriasisinthenetherlandsanonlinesurveystudyamongstpatientsandphysicians
AT spulspi currentextentofandneedforshareddecisionmakinginatopicdermatitisandpsoriasisinthenetherlandsanonlinesurveystudyamongstpatientsandphysicians